Feasibility Study of Photovaporisation of Prostate With a Limitated Length of Catheterization of 3 Hours
Feasibility Study of Photovaporisation of Prostate With a Limitated Length of Catheterization of 3 Hours
Benign hypertrophy of the prostate (BPH) is the most frequent pathology in the urinary tract
 of middle-aged men. In recent years, to enable BPH treatment with larger volumes and to
 reduce the risk of hemorrhage known to be associated to the transurethral resection of
 prostate treatment, transurethral photovaporisation of the prostate (PVP ) with the
 GreenLight (GL) XPS 180 W was developed. Therefore, the question arises to maximally reduce
 the length of catheterization to facilitate outpatient surgical management of prostate
 adenoma.

 In the investigators study, the investigators propose to evaluate the failure rate of an
 early removal of the catheter 3 hours post-operative after a PVP procedure with GL 180 W/XPS
 in selected patients on general anesthesia or spinal anesthesia. To this end, the
 investigators realize a national multicenter prospective study including 300 patients. The
 effectiveness of this model of management is defined by absence of a need for
 re-catheterization in the post -operative period of 24 hours.
Inclusion Criteria:

 1. patients with lower urinary tract symptoms (LUTS )

 2. IPSS≥ 15 despite medical treatment > 1 month if monotherapy or > 3 months if
 bitherapie OR acute urinary retention ( RAU ) non-medical after the 1st failure to
 remove the catheter OR acute prostatitis OR macroscopic haematuria of prostatic origin

 3. prostate volume > 30 cc by transrectal ultrasonography ;

 4. IPSS Qol ≥ 3 has at inclusion ;

 5. PSA ≤ 4 ng / ml ;

 6. if PSA between 4 and 10 then PSA L/T ≥25 % or negative PBP <6 months .

 7. Accommodation <50 km;

 8. company available for the return at home and monitoring first post- operative night .

 9. patient sign the informed consent

 10. patient covered by social security or other health insurance

 Exclusion criteria

 1. post- voiding residue > 250 cc by suprapubic ultrasound not older than < 45 days

 2. prostate volume > 100 cc by transrectal ultrasound not older than 45 days

 3. urological antecedents : o urethral stenosis or cervical disease

 -  UTI in progress

 -  SAD patient or self-catheterization

 -  obstructive hydronephrosis + / - renal failure

 -  vesical calculi

 -  cancer of the prostate treated or untreated

 -  bladder tumor associated

 -  Interstitial cystitis ( symptom or biopsy)

 4. antecedent of the prostate surgery

 5. neurologic bladder ( parkinsonian syndrome , multiple sclerosis , lupus, neuropathy,
 Diabetic, cauda equina syndrome )

 6. criteria related concomitant medications that can not be stopped at least < 48 hours
 before PVP with GL XPS 180 W

 7. contra indication for outpatient care for medical reason

 8. contra indication of a product analgesic according to protocol

 9. patient inability to understand and sign the informed consent as well as completing
 the questionnaires

 10. ASA Score > 3 .